Skip to main content
. 2012 Sep 20;13:177. doi: 10.1186/1471-2474-13-177

Table 3.

Changes in primary and secondary outcomes

Variablea Studies (#) ES (#) Participants (#) x¯(95% CI) Z(p) Q(p) I2 (%) 95% PI
Primary
- Femoral neck
21
28
1632
0.288 (0.102, 0.474)
3.03(0.002)*
90.5(p <0.0001)*
70.1
−0.568, 1.142
- Lumbar spine
21
28
1504
0.179 (−0.003, 0.361)
1.93(0.05)*
77.7(<0.0001)*
65.3
−0.614, 0.972
Secondary
- Ward’s triangle
6
8
252
0.260 (−0.405, 0.613)
0.40(0.69)
28.1(<0.0001)*
75.1
−1.567, 1.775
- Total hip
10
14
734
0.232 (0.073, 0.391)
2.86(0.004)*
17.6(0.18)
26.0
−0.149, 0.613
- Trochanteric
14
21
1085
0.222 (0.107, 0.337)
3.79(<0.0001)*
18.3(0.57)
0
0.099, 0.345
- Intetrochanteric
6
10
399
0.241 (0.058, 0.425)
2.58(0.01)*
8.3(0.50)
0
0.024, 0.458
- Whole body
6
7
246
0.121 (−0.055, 0.298)
1.35(0.18)
2.7(0.85)
0
−0.110, 0.352
- Radius - 1/3
2
4
182
0.048 (−0.329, 0.424)
0.25(0.81)
5.8(0.12)
48.2
−1.365, 1.461
- Radius – mid
2
4
182
0.153 (−0.262, 0.568)
0.72(0.47)
7.0(0.07)**
57.2
−1.496, 1.802
- Radius – ultradistal
2
4
182
0.263 (−0.239, 0.765)
1.03(0.31)
10.1(0.02)*
70.3
−1.886, 2.412
- Aerobic fitness
5
8
198
1.146 (0.31, 1.930)
2.86(0.004)*
47.0(p <0.0001)*
85.1
−1.539, 3.831
- Dynamic balance
4
5
95
1.39 (0.766, 2.014)
4.37(<0.0001)*
18.9(0.001)*
78.9
−0.856, 3.636
- Static balance
5
7
112
0.841 (0.228, 1.454)
2.69(0.007)*
40.9(<0.0001)*
85.3
−1.254, 2.936
- Body weight (kg)
11
17
594
−0.03 (−0.4, 0.4)
−0.15(0.88)
13.0(0.67)
0
−0.5, 0.4
- Body mass index (kg/m2)
8
11
511
−0.2 (−0.8, 0.4)
−0.69(0.49)
109.9(<0.0001)*
90.9
−2.3, 1.9
- Lean body mass (kg)
7
10
461
0.4 (−0.06, 0.9)
1.72(0.09)**
23.8(0.005)*
62.1
−1.0, 1.9
- Fat mass (kg)
4
6
230
−0.5 (−1.2, 0.2)
−1.48(0.14)
11.0(0.05)*
54.6
−2.4, 1.4
- Body fat (%)
5
7
211
−1.7 (−2.8, -0.8)
−3.58(<0.0001)*
13.1(0.04)*
54.1
−4.4, 0.8
- Strength (upper body)
7
9
300
2.01 (1.08, 2.95)
4.24(<0.0001)*
97.8(<0.0001)*
97.8
−1.33, 5.36
- Strength (lower body)
9
12
482
1.58 (0.91, 2.24)
4.67(<0.0001)*
120.9(<0.0001)*
90.9
−1.00, 4.10
- Calcium intake (mg)
5
7
319
10.1 (−15.8, 35.9)
0.76(0.45)
0.3(1.0)
0
−23.9, 44.0
- Vitamin D (mcg) -- -- -- -- -- -- -- --

Notes: aUnless noted otherwise, all outcomes are reported as standardized effect size (g); ES, effect size; #, number; Z(p), z-score and alpha value; Q(p), Cochran’s Q statistic and alpha value; I2 (%), I-squared; PI, prediction intervals. *, statistically significant (p ≤ 0.05; **trend for statistical significance (p >0.05 to ≤ 0.10); --, Insufficient data reported (< 3 ES’s).